peripheral blood
-
not specified
RNA-seq; RT-qPCR; Clinical Sample Validation; Survival Analysis
high circCORO1C expression is associated with shorter TTFT and OS
circCORO1C is specifically overexpressed in t(14;19) CLL compared with healthy B cells (validated by RT-qPCR). High circCORO1C expression predicts worse outcomes, including shorter time to first treatment and overall survival.
0.4679
Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study.
combined biological and clinical study